288 related articles for article (PubMed ID: 23050645)
1. Poly-ICLC preconditioning protects the blood-brain barrier against ischemic injury in vitro through type I interferon signaling.
Gesuete R; Packard AE; Vartanian KB; Conrad VK; Stevens SL; Bahjat FR; Yang T; Stenzel-Poore MP
J Neurochem; 2012 Nov; 123 Suppl 2(Suppl 2):75-85. PubMed ID: 23050645
[TBL] [Abstract][Full Text] [Related]
2. Cytosolic Receptor Melanoma Differentiation-Associated Protein 5 Mediates Preconditioning-Induced Neuroprotection Against Cerebral Ischemic Injury.
Gesuete R; Christensen SN; Bahjat FR; Packard AE; Stevens SL; Liu M; Salazar AM; Stenzel-Poore MP
Stroke; 2016 Jan; 47(1):262-6. PubMed ID: 26564103
[TBL] [Abstract][Full Text] [Related]
3. Activation of toll-like receptor signaling pathway for protection against influenza virus infection.
Wong JP; Christopher ME; Viswanathan S; Karpoff N; Dai X; Das D; Sun LQ; Wang M; Salazar AM
Vaccine; 2009 May; 27(25-26):3481-3. PubMed ID: 19200852
[TBL] [Abstract][Full Text] [Related]
4. Astrocytic Toll-like receptor 3 is associated with ischemic preconditioning-induced protection against brain ischemia in rodents.
Pan LN; Zhu W; Li Y; Xu XL; Guo LJ; Lu Q; Wang J
PLoS One; 2014; 9(6):e99526. PubMed ID: 24914679
[TBL] [Abstract][Full Text] [Related]
5. Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models.
Zhu X; Nishimura F; Sasaki K; Fujita M; Dusak JE; Eguchi J; Fellows-Mayle W; Storkus WJ; Walker PR; Salazar AM; Okada H
J Transl Med; 2007 Feb; 5():10. PubMed ID: 17295916
[TBL] [Abstract][Full Text] [Related]
6. Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent manners.
Zhu X; Fallert-Junecko BA; Fujita M; Ueda R; Kohanbash G; Kastenhuber ER; McDonald HA; Liu Y; Kalinski P; Reinhart TA; Salazar AM; Okada H
Cancer Immunol Immunother; 2010 Sep; 59(9):1401-9. PubMed ID: 20549206
[TBL] [Abstract][Full Text] [Related]
7. Dose and regimen effects of poly ICLC, an interferon inducer, in a multi-dose bleomycin model of interstitial pulmonary fibrosis.
Wild JS; Hyde DM; Giri SN
Pharmacol Toxicol; 1994 Jul; 75(1):42-8. PubMed ID: 7526360
[TBL] [Abstract][Full Text] [Related]
8. Interferon protects mice against inhalation anthrax.
Walberg K; Baron S; Poast J; Schwartz B; Izotova L; Pestka S; Peterson JW
J Interferon Cytokine Res; 2008 Oct; 28(10):597-601. PubMed ID: 18778201
[TBL] [Abstract][Full Text] [Related]
9. Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans.
Caskey M; Lefebvre F; Filali-Mouhim A; Cameron MJ; Goulet JP; Haddad EK; Breton G; Trumpfheller C; Pollak S; Shimeliovich I; Duque-Alarcon A; Pan L; Nelkenbaum A; Salazar AM; Schlesinger SJ; Steinman RM; Sékaly RP
J Exp Med; 2011 Nov; 208(12):2357-66. PubMed ID: 22065672
[TBL] [Abstract][Full Text] [Related]
10. Apelin-13 Protects against Ischemic Blood-Brain Barrier Damage through the Effects of Aquaporin-4.
Chu H; Yang X; Huang C; Gao Z; Tang Y; Dong Q
Cerebrovasc Dis; 2017; 44(1-2):10-25. PubMed ID: 28402976
[TBL] [Abstract][Full Text] [Related]
11. Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3.
Marsh B; Stevens SL; Packard AE; Gopalan B; Hunter B; Leung PY; Harrington CA; Stenzel-Poore MP
J Neurosci; 2009 Aug; 29(31):9839-49. PubMed ID: 19657036
[TBL] [Abstract][Full Text] [Related]
12. Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis.
Sionov E; Mayer-Barber KD; Chang YC; Kauffman KD; Eckhaus MA; Salazar AM; Barber DL; Kwon-Chung KJ
PLoS Pathog; 2015 Aug; 11(8):e1005040. PubMed ID: 26252005
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis of acute respiratory virus infections using nucleic acid-based drugs.
Wong JP; Nagata LP; Christopher ME; Salazar AM; Dale RM
Vaccine; 2005 Mar; 23(17-18):2266-8. PubMed ID: 15755608
[TBL] [Abstract][Full Text] [Related]
14. Novel antiviral therapeutics to control foot-and-mouth disease.
Dias CC; Moraes MP; Weiss M; Diaz-San Segundo F; Perez-Martin E; Salazar AM; de los Santos T; Grubman MJ
J Interferon Cytokine Res; 2012 Oct; 32(10):462-73. PubMed ID: 22924938
[TBL] [Abstract][Full Text] [Related]
15. Liposome-mediated immunotherapy against respiratory influenza virus infection using double-stranded RNA poly ICLC.
Wong JP; Yang H; Nagata L; Kende M; Levy H; Schnell G; Blasetti K
Vaccine; 1999 Mar; 17(13-14):1788-95. PubMed ID: 10194841
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism.
Leung PY; Stevens SL; Packard AE; Lessov NS; Yang T; Conrad VK; van den Dungen NN; Simon RP; Stenzel-Poore MP
Stroke; 2012 May; 43(5):1383-9. PubMed ID: 22403050
[TBL] [Abstract][Full Text] [Related]
17. Enhanced induction of plasma interferon after subcutaneous administration in rabbits of poly ICLC with albumin.
Pessina GP; Muscettola M; Paulesu L; Bocci V
J Biol Regul Homeost Agents; 1989; 3(3):118-21. PubMed ID: 2483023
[TBL] [Abstract][Full Text] [Related]
18. The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system.
Echeverry R; Wu F; Haile WB; Wu J; Yepes M
J Neuroinflammation; 2012 Mar; 9():45. PubMed ID: 22394384
[TBL] [Abstract][Full Text] [Related]
19. Activation of natural killer cells in newborn piglets by interferon induction.
Lesnick CE; Derbyshire JB
Vet Immunol Immunopathol; 1988 Mar; 18(2):109-17. PubMed ID: 2838948
[TBL] [Abstract][Full Text] [Related]
20. Activation of interferon response through toll-like receptor 3 impacts viral pathogenesis and pulmonary toll-like receptor expression during respiratory syncytial virus and influenza infections in the cotton rat Sigmodon hispidus model.
Boukhvalova MS; Sotomayor TB; Point RC; Pletneva LM; Prince GA; Blanco JC
J Interferon Cytokine Res; 2010 Apr; 30(4):229-42. PubMed ID: 20038196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]